Bayer Pharma AG et al v. Cipla Ltd. et al > Summary
Court Case Number 1:23-cv-01196
Filing Date Oct 20, 2023
Court Delaware District Court
Status Unknown
JudgesRichard G. Andrews
Plaintiff Attorneys
9JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Derek J. Fahnestock
Morris Nichols Arsht & Tunnell
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Rodger D. Smith II
Morris Nichols Arsht & Tunnell
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Derek J. Fahnestock
Morris Nichols Arsht & Tunnell
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Rodger D. Smith II
Morris Nichols Arsht & Tunnell
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Derek J. Fahnestock
Morris Nichols Arsht & Tunnell
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Rodger D. Smith II
Morris Nichols Arsht & Tunnell
Defendant Attorneys
6InvaGen Pharmaceuticals, Inc.
Attorney Name: John M. Seaman
Abrams & Bayliss LLP
InvaGen Pharmaceuticals, Inc.
Attorney Name: April M. Ferraro
Abrams & Bayliss LLP
InvaGen Pharmaceuticals, Inc.
Attorney Name: John M. Seaman
Abrams & Bayliss LLP
InvaGen Pharmaceuticals, Inc.
Attorney Name: April M. Ferraro
Abrams & Bayliss LLP
InvaGen Pharmaceuticals, Inc.
Attorney Name: John M. Seaman
Abrams & Bayliss LLP
Related Patents
Doc No | Title | Issue date |
---|---|---|
10828310 | Reducing the risk of cardiovascular events | Nov 10, 2020 |